We are live on ! Find out more
BWLSA

Blue Water Life Science Advisors Portfolio holdings

AUM $159M
1-Year Est. Return 139.66%
This Fund
S&P 500
This Quarter Est. Return
+39.64%
1 Year Est. Return
+139.66%
3 Year Est. Return
+503.09%
5 Year Est. Return
+228.74%
10 Year Est. Return
–
AUM
$205M
AUM Growth
+$34.3M
Cap. Flow
+$18.6M
Cap. Flow %
9.1%
Top 10 Hldgs %
96.81%
Holding
26
New
5
Increased
6
Reduced
1
Closed
2

Top Buys

Rank Stock Value
1
EXAS
Exact Sciences
EXAS
+$12.6M
2
GH icon
Guardant Health
GH
+$6.71M
3
CDNA icon
CareDx
CDNA
+$4.97M
4
NTRA icon
Natera
NTRA
+$4.83M
5
A icon
Agilent Technologies
A
+$2.59M

Top Sells

Rank Stock Value
1
TWST icon
Twist Bioscience
TWST
+$10.3M
2
GNMK
GenMark Diagnostics, Inc
GNMK
+$6.81M
3
CELL
PhenomeX Inc. Common Stock
CELL
+$2.28M

Sector Composition

Rank Sector Weight
1 Healthcare 77.85%
2 Materials 19.52%
3 Technology 1.04%
4 Financials 0.45%
5 Communication Services 0.31%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
GNMK
26
DELISTED
GenMark Diagnostics, Inc
GNMK
– –
-466,337
Closed -$6.81M
1
2

Similar funds

SFC
Swisher Financial Concepts Westerville, Ohio $159M AUM 23.09% 1-Year Est. Return
ACP
Argyle Capital Partners Los Angeles, California $159M AUM 21.07% 1-Year Est. Return
CW
Cooksen Wealth The Woodlands, Texas $159M AUM 23.21% 1-Year Est. Return
SG
Stanich Group Montauk, New York $159M AUM 24.04% 1-Year Est. Return
LA
Lakeside Advisors Seattle, Washington $159M AUM 11.13% 1-Year Est. Return
CMMS
Comprehensive Money Management Services Coral Gables, Florida $159M AUM 18.94% 1-Year Est. Return
JWM
JP Wealth Management Mt. Pleasant, South Carolina $159M AUM 19.83% 1-Year Est. Return
AC
Agman Capital Omaha, Nebraska $159M AUM

Blue Water Life Science Advisors's Q1 2021 Portfolio in Review

As of Q1 2021, Blue Water Life Science Advisors held 26 positions worth $205M, up 20% from $170M the previous quarter. Its ten largest holdings account for 97% of the portfolio.

Blue Water Life Science Advisors deployed $18.6M of net new capital in Q1 2021, opening 5 new positions and adding to 6 existing holdings. Its largest new stake was Agilent Technologies: 20,938 shares worth $2.66M.

By sector, the portfolio is most concentrated in Healthcare at 78% of assets, down from 90% a quarter earlier, followed by Materials and Technology.

On the sell side, the largest reduction was PhenomeX Inc. Common Stock, an estimated $2.28M trimmed.

  • Blue Water Life Science Advisors's largest Q1 2021 buy was Agilent Technologies: 20,938 shares worth $2.66M.
  • Blue Water Life Science Advisors added most to Exact Sciences in Q1 2021, an estimated $12.6M increase.
  • Blue Water Life Science Advisors's biggest Q1 2021 reduction was PhenomeX Inc. Common Stock, cutting an estimated $2.28M.
  • Blue Water Life Science Advisors fully exited Twist Bioscience in Q1 2021, selling an estimated $10.3M.
  • Blue Water Life Science Advisors's ten largest holdings make up 97% of its $205M portfolio in Q1 2021.
  • Blue Water Life Science Advisors opened 5 new positions and closed 2 in Q1 2021.
  • Blue Water Life Science Advisors's portfolio value rose 20% quarter-over-quarter to $205M.

Based on Blue Water Life Science Advisors's 13F filing for Q1 2021, filed 14 May 2021.